This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Graco (GGG) Lags Q1 Earnings Estimates, Withdraws Sales View
by Zacks Equity Research
Graco's (GGG) first-quarter earnings suffer from weak revenue generation and a decline in margins. It suspends revenue projections for the year due to economic uncertainties.
Industrial Stock Q1 Earnings Due on Apr 22: GGG, MSA & More
by Zacks Equity Research
The impacts of the coronavirus outbreak and countermeasures, cost-related woes, and other headwinds might get reflected in Q1 results of the majority of industrial stocks.
Here's Why Investors Should Ignore Flowserve (FLS) for Now
by Zacks Equity Research
Flowserve's (FLS) operations are exposed to uncertainties caused by the coronavirus outbreak. Also, high debts, realignment expenses and forex woes might be concerning.
Nordson (NDSN) Gains From Buyouts Despite Segmental Woes
by Zacks Equity Research
Nordson (NDSN) is likely to benefit from strength in its medical product end markets, growth initiatives and buyouts. Weak Advanced Technology Systems segment and high cost of sales remain concerning.
Applied Industrial Gains From Buyouts Despite Market Woes
by Zacks Equity Research
Applied Industrial (AIT) to gain from cost-saving measures, acquisitions and shareholder-friendly policies. Softness in industrial demand might impact near-term results.
Colfax (CFX) Displays Bright Prospects, Headwinds Remain
by Zacks Equity Research
Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses, productivity actions and acquisitions. However, rising cost of sales and high debt remain concerns.
3M (MMM) Collaborates With Ford to Combat Coronavirus Crisis
by Zacks Equity Research
3M (MMM) partners with Ford to increase the production of powered air purifying respirators in its bid to contribute toward the fight against the coronavirus pandemic.
Crane (CR) to Benefit From Acquisitions, Headwinds Persist
by Zacks Equity Research
Crane (CR) is likely to benefit from its focus on product development, strong operating leverage, repositioning activities and acquired asset. However, high debt and segmental woes remain concerns.
Honeywell Increases Face Mask Production to Fight Coronavirus
by Zacks Equity Research
Honeywell (HON) increases production of healthcare materials in its bid to contribute toward the fight against the coronavirus pandemic.
iRobot (IRBT) Withdraws Annual View on Coronavirus Concerns
by Zacks Equity Research
Due to the pandemic, iRobot (IRBT) lowers sales view for first-quarter 2020 and withdraws annual projections. It expects to witness relief if Roomba products get excluded from Section 301 tariffs.
Enersys Gains From Solid Demand & Buyouts Amid Cost Woes
by Zacks Equity Research
Enersys (ENS) benefits from strength in its transportation business, solid demand for NexSys TPPL products and buyout of Alpha Technologies. However, rising cost of sales and high debt remain concerns.
Enerpac Tool (EPAC) Lags on Q2 Earnings, Discontinues View
by Zacks Equity Research
Enerpac Tool (EPAC) Q2 results reflect weak sales and operating performance. It discontinues the fiscal 2020 projections due to volatility in oil prices and the coronavirus outbreak.
Cintas (CTAS) Q3 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Cintas' (CTAS) third-quarter fiscal 2020 earnings and revenues increase year over year due to strong performance in its segmental businesses.
IDEX (IEX) Authorizes Share Repurchase Program Worth $500M
by Zacks Equity Research
IDEX's (IEX) approval of an additional share repurchase program worth $500 million is likely to instill confidence among investors.
Honeywell Unveils Analytics Platform for Aviation Industry
by Zacks Equity Research
Honeywell's (HON) Forge platform empowers aviation customers with a user friendly, integrated dashboard that helps in sending instant alerts on issues related to connectivity and flight plan changes.
Dover (DOV) to Buy Em-tec, Sees Growth in Biopharma Market
by Zacks Equity Research
The latest acquisition will help Dover (DOV) expand its offerings into biopharma and other hygienic applications.
Industrial Production Up M/M in February: 5 Stocks to Buy
by Payal Jalan
Industrial production rises m/m in February on strong manufacturing and utilities sectors. In spite of the rebound, the coronavirus threat remains. Amid this, five stocks might boost your portfolio.
Roper's (ROP) Rate Prediction Tools to be Used by Choptank
by Zacks Equity Research
Roper's (ROP) business unit, DAT Solutions' forecasting tools generate rate predictions on the basis of price momentum, prevailing market conditions as well as five years of historic data.
Roper (ROP) Displays Bright Prospects, Headwinds Persist
by Zacks Equity Research
Roper (ROP) is likely to benefit from strength across its network software and medical products businesses, and acquisitions. However, soft Process Technologies segment is a concern.
Emerson (EMR) Launches Data Visualization Software Solution
by Zacks Equity Research
Emerson's (EMR) Micro Motion ProcessViz software solution supports its Micro Motion transmitters to provide plant operators with a snapshot of the flow process.
Parker-Hannifin Discusses Strategies and Long-Term Targets
by Zacks Equity Research
Parker-Hannifin's (PH) recent investor meeting shines a light on its organic initiatives, long-term financial targets and capital allocation plans.
Here's Why Investors Should Bet on Tetra Tech (TTEK) Stock
by Zacks Equity Research
Favorable trends in Tetra Tech's (TTEK) client businesses along with WYG and eGlobalTech buyouts augur well for its growth.
Emerson Acquires Verdant, Strengthens Product Portfolio
by Zacks Equity Research
Emerson's (EMR) buyout of Verdant will enable it to boost portfolio of thermostat and sustainability solutions for the hotel and hospitality industries.
Chart Industries Authorizes $75M Share Repurchase Program
by Zacks Equity Research
Chart Industries (GTLS) remains committed toward rewarding its shareholders handsomely through share buyback programs.
Here's Why it is Worth Investing in Tennant (TNC) Stock Now
by Zacks Equity Research
Tennant (TNC) is likely to gain from product innovation, investments to expand capacity and synergistic benefits from acquired assets. Also, shareholder-friendly policies enhance its attractiveness.